Literature DB >> 33717049

Differential Elevation of Inflammation and CD4+ T Cell Activation in Kenyan Female Sex Workers and Non-Sex Workers Using Depot-Medroxyprogesterone Acetate.

Kenneth Omollo1,2, Julie Lajoie1,3, Julius Oyugi1,3, Jocelyn M Wessels4, Dufton Mwaengo1, Joshua Kimani1,2, Charu Kaushic4,5, Keith R Fowke1,2,3,6.   

Abstract

Background: Depot Medroxyprogesterone (DMPA) is one of the most widely used contraceptives in Sub-Saharan Africa where HIV incidence is high. We explored the effect of DMPA on the activation of HIV cellular targets and inflammation as a possible mechanism of increased HIV risk with DMPA use. Since sex work is known to affect the immune system, this study aimed to understand the effect of DMPA on the immune system among sex workers and non-sex worker women.
Methods: Twenty-seven DMPA-using HIV seronegative female sex workers (FSW) and 30 DMPA-using HIV seronegative non-sex worker (SW) women were enrolled in the study. Twenty-four FSWs and 30 non-sex workers who were not using any hormonal contraception (no HC) were recruited as controls. Blood and cervico-vaginal samples were collected from all participants and assayed for T cell activation and proinflammatory cytokines.
Results: Among no HC users, sex workers had lower expression of CD38 and CD69 on blood-derived CD4+ T cells along with lower CD4+CCR5+ cells frequency in the endocervix. Plasma MCP-1, TNFα and IL-17 also had reduced expression in FSW not using HC. Non-sex workers using DMPA had elevated proportions of blood-derived CD4+CD38+, CD4+CD69+ and CD4+HLA-DR+ T cells relative to non-sex workers who were not taking any HC. DMPA-using non-sex workers also had an increased level of plasma interferon gamma (IFN-γ), monokine induced by interferon-γ (MIG) and sCD40L, alongside higher proportion of CD4+CD38+ and CD4+CD69+ T cells at the cervix compared to non-sex workers no-HC controls., Finally, non-sex workers and FSWs using DMPA had similar levels of genital and peripheral CD4+ T cell activation and inflammation.
Conclusion: DMPA increased inflammation and expression of activation markers on potential HIV target cells in non-sex workers. These data show that DMPA is a strong immune modulator and its use counteracts the decreased immune activation associated with sex work. These findings suggest that inflammation and increased HIV target cells in blood and at the genital tract may be mechanisms by which DMPA increases susceptibility to HIV.
Copyright © 2021 Omollo, Lajoie, Oyugi, Wessels, Mwaengo, Kimani, Kaushic and Fowke.

Entities:  

Keywords:  DMPA; HIV target cells; T-cell activation; commercial sex workers; endocervix; inflammation

Mesh:

Substances:

Year:  2021        PMID: 33717049      PMCID: PMC7949914          DOI: 10.3389/fimmu.2020.598307

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  45 in total

1.  Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus.

Authors:  David J Sharkey; Kelton P Tremellen; Melinda J Jasper; Kristina Gemzell-Danielsson; Sarah A Robertson
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

2.  A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers.

Authors:  J Lajoie; J Juno; A Burgener; S Rahman; K Mogk; C Wachihi; J Mwanjewe; F A Plummer; J Kimani; T B Ball; K R Fowke
Journal:  Mucosal Immunol       Date:  2012-02-08       Impact factor: 7.313

3.  Risk Factors for HIV Acquisition in a Prospective Nairobi-Based Female Sex Worker Cohort.

Authors:  Lyle R McKinnon; Preston Izulla; Nico Nagelkerke; Julius Munyao; Tabitha Wanjiru; Souradet Y Shaw; Richard Gichuki; Cecilia Kariuki; Festus Muriuki; Helgar Musyoki; Gloria Gakii; Lawrence Gelmon; Rupert Kaul; Joshua Kimani
Journal:  AIDS Behav       Date:  2015-12

4.  Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.

Authors:  Elizabeth H Byrne; Melis N Anahtar; Kathleen E Cohen; Amber Moodley; Nikita Padavattan; Nasreen Ismail; Brittany A Bowman; Gregory S Olson; Amanda Mabhula; Alasdair Leslie; Thumbi Ndung'u; Bruce D Walker; Musie S Ghebremichael; Krista L Dong; Douglas S Kwon
Journal:  Lancet Infect Dis       Date:  2015-12-24       Impact factor: 25.071

5.  Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection.

Authors:  Grant R Yeaman; Alexandra L Howell; Sally Weldon; Douglas J Demian; Jane E Collins; Denise M O'Connell; Susana N Asin; Charles R Wira; Michael W Fanger
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

6.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.

Authors:  H L Martin; P M Nyange; B A Richardson; L Lavreys; K Mandaliya; D J Jackson; J O Ndinya-Achola; J Kreiss
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

7.  A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.

Authors:  Charles S Morrison; Raina Fichorova; Pai-Lien Chen; Cynthia Kwok; Jennifer Deese; Hidemi Yamamoto; Sharon Anderson; Tsungai Chipato; Robert Salata; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2018-09-05       Impact factor: 2.205

8.  Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst.

Authors:  Francisco Dominguez; Arancha Galan; Jose Juan Luna Martin; Jose Remohi; Antonio Pellicer; Carlos Simón
Journal:  Mol Hum Reprod       Date:  2003-04       Impact factor: 4.025

9.  Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.

Authors:  Neelima Chandra; Andrea Ries Thurman; Sharon Anderson; Tina Duong Cunningham; Nazita Yousefieh; Christine Mauck; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-28       Impact factor: 2.205

10.  Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells.

Authors:  Catherine M Card; Paul J McLaren; Charles Wachihi; Joshua Kimani; Francis A Plummer; Keith R Fowke
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

View more
  4 in total

Review 1.  The Penis, the Vagina and HIV Risk: Key Differences (Aside from the Obvious).

Authors:  Rupert Kaul; Cindy M Liu; Daniel E Park; Ronald M Galiwango; Aaron A R Tobian; Jessica L Prodger
Journal:  Viruses       Date:  2022-05-27       Impact factor: 5.818

2.  The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion.

Authors:  Christophe Vanpouille; Gökçe Günaydın; Mattias Jangard; Mario Clerici; Leonid Margolis; Kristina Broliden; Andrea Introini
Journal:  Viruses       Date:  2021-11-18       Impact factor: 5.048

3.  Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate.

Authors:  Frideborg Bradley; Mathias Franzén Boger; Vilde Kaldhusdal; Alexandra Åhlberg; Gabriella Edfeldt; Julie Lajoie; Sofia Bergström; Kenneth Omollo; Anastasios Damdimopoulos; Paulo Czarnewski; Anna Månberg; Julius Oyugi; Joshua Kimani; Peter Nilsson; Keith Fowke; Annelie Tjernlund; Kristina Broliden
Journal:  PLoS Pathog       Date:  2022-05-09       Impact factor: 6.823

4.  Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.

Authors:  Smritee Dabee; Ramla F Tanko; Bryan P Brown; Rubina Bunjun; Christina Balle; Colin Feng; Iyaloo N Konstantinus; Shameem Z Jaumdally; Maricianah Onono; Gonasagrie Nair; Thesla Palanee-Phillips; Katherine Gill; Jared M Baeten; Linda-Gail Bekker; Jo-Ann S Passmore; Renee Heffron; Heather B Jaspan; Anna-Ursula Happel
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.